Company intelligence / Profile preview
Antibody Therapeutics
San Francisco Bay Area, California, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Antibody Therapeutics develops next-generation therapeutic antibodies using a proprietary platform spun out of Antibody Studio, applying advanced discovery to generate novel antibody therapeutics. Clinical stage programs have not been announced as of October 2025.
- Modalities
- AntibodyMonoclonal antibodyBispecific monoclonal antibody
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
Genor Biopharma
Beyond the preview
Go deeper on Antibody Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Antibody Therapeutics.